SAN JOSE -- A Stanford University genetics professor has paid nearly $30 million in restitution after a judge determined that he misled investors in a now-dissolved biotechnology company he founded.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant. Adam Feuerstein is a senior writer and biotech ...

Tessier-Lavigne, a neuroscientist and biotech entrepreneur ... 2023 Before he became Stanford’s president, Tessier-Lavigne served as president of Rockefeller University in New York, oversaw ...

Baker is a rising sophomore at Stanford University. At its daily student ... investigation found that as a neuroscientist and biotechnology executive, he had fostered an environment that led ...

Finnish biotech startup Solu has raised $1 million in a round led by Oura-backer Lifeline Ventures. Solu is working with Stanford University to solve the growing problem of antibiotic resistance.

July 19 (Reuters) - The president of Stanford University, one of the most prestigious ... president of research drug discovery at the U.S. biotechnology company Genentech Inc. But the review ...

By Stephanie Saul Following months of intense scrutiny of his scientific work, Marc Tessier-Lavigne announced Wednesday that he would resign as president of Stanford University after an ...